Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,106 Gastrointestinal
clinical trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
IMIC Research
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Bioclinica Research Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
California Liver Research Institute
mi
from
Pasadena, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southern California Liver Centers - San Clemente
mi
from
San Clemente, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Research and Education-Tuan Nguyen MD
mi
from
San Diego, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Other Clinical Trial
Outcome Analysis of POEM and Endoluminal Therapies
Status: Enrolling
Updated: 12/31/1969
Univesity of California Davis Health System
mi
from
Sacramento, CA
Click here to add this to my saved trials
Gastroenterology, Rheumatology, Orthopedics / Podiatry Clinical Trial
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
Status: Enrolling, Phase I
Updated: 12/31/1969
West Coast Clinical Trials (WCCT)
mi
from
Cypress, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Avant Research Associates, LLC - Beaumont
mi
from
Beaumont, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolinas HealthCare System Digestive Health
mi
from
Charlotte, NC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center - University Cardiovascular Surgeons
mi
from
Chicago, IL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Universal Axon Clinical Research, LLC
mi
from
Doral, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Research, LLC
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Internal Medicine Specialists
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovation Research Institute, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Facey Medical Foundation (Parent)
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Bayside Clinical Research
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
NSB Research
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
DM Clinical Research
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Palo Alto Center-Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Clinical Research, LLC
mi
from
Petersburg, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Theia Clinical Research
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Ygenics
mi
from
Plano, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
San Antonio Gastroenterology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Medical Research, LLC
mi
from
Warren, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hope Research Development
mi
from
West Covina, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advantage Clinical Trials
mi
from
Bronx, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
TrialSpark
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advance Clinical Research - Dayton Internal Medicine
mi
from
Dayton, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolina Research Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
CroNOLA, LLC
mi
from
Houma, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
GI Specialists of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Michigan University Homer Stryker MD School of Medicine
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid America Gastrointestinal Consultants
mi
from
Kansas City, MO
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Franciscan Skemp Healthcare
mi
from
La Crosse, WI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Clinical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Alliance Medical Research LLC
mi
from
Lighthouse Point, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Nova Clinical Research Center LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Omega Research Maitland
mi
from
Orlando, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Revive Research Institute
mi
from
Southfield, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Gastroenterology
mi
from
Union City, TN
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling, Phase II
Updated: 12/31/1969
MHAT Saint Karidad EAD
mi
from
Plovdiv,
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alberta Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Om Research
mi
from
Lancaster, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Lucas Research, Inc.
mi
from
Morehead City, NC
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
ACRC Studies
mi
from
Poway, CA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]
Status: Enrolling, Phase II
Updated: 12/31/1969
Gastro Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Inguinal Hernia Clinical Trial
Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management
Status: Enrolling, Phase I, II
Updated: 12/31/1969
JBR Clinical Research
mi
from
Draper, UT
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Pediatric Gastroenterology
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns
Status: Enrolling
Updated: 12/31/1969
HonorHealth Scottsdale Osborn Medical Center
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling, Phase II
Updated: 12/31/1969
Research by Design, LLC
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana University School of Medicine - Indianapolis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis Clinical Trial
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM)
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Edegem,
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Peak Gastroenterology Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Asthma and Allergy Associates PC - CRN
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling, Phase III
Updated: 12/31/1969
Consultants for Clinical Research
mi
from
Fairfield, OH
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Institute of Michigan - Interspond - PPDS
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Research, LLC
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
DelRicht Clinical Research, LLC
mi
from
New Orleans, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Status: Enrolling, Phase III
Updated: 12/31/1969
DBC Research
mi
from
Tamarac, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Phoenician Centers for Research and Innovation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Brigham and Women's Hospital - Crohn's and Colitis Center
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Adirondack Medical Research Center
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Qway Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Vista Health Research
mi
from
Homestead, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kentucky Health Care
mi
from
Lexington, KY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
VA Northern California Health Care System
mi
from
Mather, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Associates of South Florida, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
HMD Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Asclepes Research Centers
mi
from
Weeki Wachee, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Reseach of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Om Research
mi
from
Lancaster, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Medical Center - New Center One
mi
from
Novi, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Accurate Clinical Research Inc
mi
from
Pasadena, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
DHAT Research Institute
mi
from
Richardson, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Sutter Medical Group
mi
from
Roseville, CA
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Peak Gastroenterology Associates
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Gastroparesis Registry 3
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts General Hospital-Digestive Healthcare Center
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Status: Enrolling, Phase
Updated: 12/31/1969
Washington Gastroenterology
mi
from
Bellevue, WA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Status: Enrolling, Phase
Updated: 12/31/1969
Del Sol Research Management, LLC
mi
from
Chandler, AZ
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Gastroenterology Assoc Southeastern Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Bozeman Health Clinical Research
mi
from
Bozeman, MT
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Ventura County Gastroenterology
mi
from
Camarillo, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley View Internal Medicine
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Om Research
mi
from
Lancaster, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Allegiance Research Specialists, LLC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
1 … 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101